News & Events

Discover new MedixMAB™ S100B antibodies

2 weeks ago

Medix Biochemica has completed the acquisition of Lee Biosolutions

2 weeks ago

Medix Biochemica expands to biomaterials for IVD industry through acquisition of Lee Biosolutions

4 weeks ago

Steve Ferguson appointed new CEO of Medix Biochemica

2 months ago

18 Nov

Medica 2019

Hall 3, booth F44

Düsseldorf, Germany

Antibodies for osteoporosis assays

3 months ago

AMH mAbs study presented at AACC

4 months ago

New Actim brochure

5 months ago

Optimal NT-proBNP antibody pairs

7 months ago

Poster presentation in EuroMedLab on May 21st

7 months ago

MedixMAB™ procalcitonin (PCT) product update

7 months ago

New MedixANTIGEN for C. difficile GDH

7 months ago

Discover new MedixMAB™ S100B antibodies

2 weeks ago

Medix Biochemica has completed the acquisition of Lee Biosolutions

2 weeks ago

Medix Biochemica expands to biomaterials for IVD industry through acquisition of Lee Biosolutions

4 weeks ago

Steve Ferguson appointed new CEO of Medix Biochemica

2 months ago

18 Nov

Medica 2019

Hall 3, booth F44

Düsseldorf, Germany

Antibodies for osteoporosis assays

3 months ago

AMH mAbs study presented at AACC

4 months ago

New Actim brochure

5 months ago

Optimal NT-proBNP antibody pairs

7 months ago

Poster presentation in EuroMedLab on May 21st

7 months ago

MedixMAB™ procalcitonin (PCT) product update

7 months ago

New MedixANTIGEN for C. difficile GDH

7 months ago